Deputy Commissioner For Policy Schultz To Leave FDA For Justice Department
This article was originally published in The Gray Sheet
Executive SummaryFDA Deputy Commissioner for Policy Bill Schultz will join the Justice Department's civil division as deputy assistant attorney general/appellate staff, effective within the next few weeks, FDA Commissioner Jane Henney announced Dec. 7.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.